Document Detail

MedLine Citation:
PMID:  22405661     Owner:  NLM     Status:  In-Data-Review    
Epidemiologic, clinical, and basic research has identified several antecedent conditions that predispose individuals to heart failure and its predecessor, asymptomatic left ventricular remodeling and dysfunction (stage B heart failure). Many biochemical markers have been described that characterize the remodeling process and the development of cardiac dysfunction. Although natriuretic peptides and cardiac troponin are currently used in the context of diagnosis, risk stratification, and management of stage C and D heart failure, many other biomarkers provide insights into the underlying pathophysiology of left ventricular dysfunction, suggesting new directions for fundamental research or the development of new therapies.
Viorel G Florea; Inder S Anand
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Heart failure clinics     Volume:  8     ISSN:  1551-7136     ISO Abbreviation:  Heart Fail Clin     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-03-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101231934     Medline TA:  Heart Fail Clin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  207-24     Citation Subset:  IM    
Copyright Information:
Published by Elsevier Inc.
Department of Medicine, University of Minnesota Medical School, 420 Delaware Street Southeast, MMC 508, Minneapolis, MN 55455, USA; Heart Failure Program, Cardiology 111-C, Minneapolis Veterans Affairs Health Care System, 1 Veterans Drive, Minneapolis, MN 55417, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Radionuclide imaging in stage B heart failure.
Next Document:  The role of Renin Angiotensin system intervention in stage B heart failure.